NephroPlus (Nephrocare Health Services) IPO GMP, Subscription & Allotment Status Today
NephroPlus (Nephrocare Health Services) is a Mainboard IPO with a price band of Rs 438.00 to Rs 460.00 that listed on 17 Dec 2025 at a listing gain of +6.52%. Track its full GMP history, subscription data and listing details here.
- Price Band
- ₹438.00 - ₹460.00
- Lot Size
- TBA
- Bidding Closes
- TBA
- Listing Date
- 17 Dec 2025
Complete IPO information
| Current GMP | ₹30 |
|---|---|
| Estimated Listing Gain | +6.52% |
| Price Band | ₹438.00 - ₹460.00 |
| Issue Price | Approx ₹460.00 Crores |
| Listing Price | ₹490.00 |
| Lot Size | TBA |
| Issue Type | Mainboard |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | TBA |
| Listing Date | 17 Dec 2025 |
| Minimum Investment | TBA |
Compare NephroPlus (Nephrocare Health Services) IPO with similar IPOs
Compare NephroPlus (Nephrocare Health Services) with any other IPO
IPO Snapshot & Investor Takeaways
The latest recorded Grey Market Premium for NephroPlus (Nephrocare Health Services) stands at ₹30, implying an estimated listing gain of around 6.52% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.
IPO roadmap at a glance
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | - | - |
| Retail Maximum | - | - | - |
| S-HNI Minimum | - | - | - |
| S-HNI Maximum | - | - | - |
| B-HNI Minimum | - | - | - |
Objects of the Issue & Official Documents
Important takeaways before applying
Listed at 490.0 for 6.52% gains
NephroPlus (Nephrocare Health Services) IPO FAQs
Comments
Share a useful question or insight about NephroPlus (Nephrocare Health Services).
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...